Skip to main content

Table 28 Hematology findings

From: ISO 10993 biological evaluation of novel hemostatic powder – 4SEAL®

Group

PT

APTT

HGB

HCT

platelets

RBC’s

WBC

Lymphocytes

Monocytes

Granulocytes

[sec.]

[sec.]

[g/dL]

[%]

[× 10 3/mm3]

[× 10 6/ mm3]

[× 10 3 /mm3]

[%]

[%]

[%]

Negative control – female

9.05

17.83

13.42

30.28

783.20

7.39

6.72

59.80

17.54

22.66

4SEAL® - female

7.80

20.08

12.80

29.30

752.40

7.23

5.40

53.50

17.36

29.02

Negative control – male

10.16

17.88

13.68

31.12

778.60

7.36

7.58

54.02

16.58

29.42

4SEAL® - male

11.28

22.08

13.16

30.16

748.80

7.39

6.14

55.24

17.88

26.88